Lessons learned from a clinical trial

被引：9

作者：

Armstrong, PW

Newby, LK

Granger, CB

Lee, KL

Simes, RJ

Van de Werf, F

White, HD

Califf, RM

机构：

[1] Univ Alberta, Dept Med, Edmonton, AB T6G 2H7, Canada

[2] Duke Clin Res Inst, Durham, NC USA

[3] Natl Hlth & Med Res Council, Sydney, NSW, Australia

[4] Univ Hosp Gasthuisberg, Gasthuisberg, Belgium

[5] Auckland City Hosp, Auckland, New Zealand

来源：

CIRCULATION | 2004年 / 110卷 / 23期

关键词：

trials; clinical; multicenter studies; biomedical research; ethics; research;

D O I：

10.1161/01.CIR.0000148680.83392.50

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3610 / 3614

页数：5

共 28 条

[1] The pharmaceutical industry - to whom is it accountable? [J].

Angell, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1902-1904

[2] CLINICAL-TRIAL DATA AND SAFETY MONITORING BOARDS - THE SEARCH FOR A CONSTITUTION [J].

ARMSTRONG, PW ;

FURBERG, CD .

CIRCULATION, 1995, 91 (03) :901-904

[3]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[4] Toward protecting the safety of participants in clinical trials [J].

Califf, RM ;

Morse, MA ;

Wittes, J ;

Goodman, SN ;

Nelson, DK ;

DeMets, DL ;

Iafrate, RP ;

Sugarman, J .

CONTROLLED CLINICAL TRIALS, 2003, 24 (03) :256-271

[5] Integrating quality into the cycle of therapeutic development [J].

Califf, RM ;

Peterson, ED ;

Gibbons, RJ ;

Garson, A ;

Brindis, RG ;

Beller, GA ;

Smith, SC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (11) :1895-1901

[6] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[7]

Cannon CP, 1998, CIRCULATION, V97, P340

[8] Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial [J].

Cannon, CP ;

McCabe, CH ;

Wilcox, RG ;

Langer, A ;

Caspi, A ;

Berink, P ;

Lopez-Sendon, J ;

Toman, J ;

Charlesworth, A ;

Anders, RJ ;

Alexander, JC ;

Skene, A ;

Braunwald, E .

CIRCULATION, 2000, 102 (02) :149-156

[9]

Chew DP, 2001, CIRCULATION, V103, P201

[10] What makes clinical research ethical? [J].

Emanuel, EJ ;

Wendler, D ;

Grady, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20) :2701-2711

← 1 2 3 →